Warburg Pincus improves liquidity in blood company
Over nearly seven years, Warburg more than doubled EBITDA at China Biologic Products and created a booming plasma-based drugs company.
14 July 2017•4 mins read
Over nearly seven years, Warburg more than doubled EBITDA at China Biologic Products and created a booming plasma-based drugs company.
Side Letter: Rated for growth
11 November 2026 · 3 mins read
Bain Capital: 'We would never tell our teams they must invest'
11 November 2026 · 5 mins read
Side Letter: Terms of endearment
10 November 2026 · 3 mins read
Bridgepoint taps former RAF chief in €1bn defense strategy launch
10 November 2026 · 4 mins read
Stacking up: How PE performs in each region
10 November 2026 · 2 mins read
Side Letter: Exits and earnings
9 November 2026 · 3 mins read
Private Take: Reading beyond the scoreboard
9 November 2026 · 4 mins read
